Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genesis Therapeutics
Biotech
Incyte pens $885M AI pact to use Genesis' GEMS to develop drugs
Incyte is offering $30 million upfront for a collaboration initially focused on two targets in severe disease.
James Waldron
Feb 20, 2025 8:00am
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
Gilead inks $35M collab with AI drug discovery outfit Genesis
Sep 10, 2024 11:40am
Fierce Medtech's Fierce 15 of 2023
Mar 4, 2024 3:00am
AI drug designer Genesis nets $200M with eye on clinical testing
Aug 21, 2023 10:45am
Genentech taps Stanford spinout for AI drug-hunting partnership
Oct 19, 2020 9:25am